OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea · Delayed Price · Currency is KRW 132,700
+7,700 (6.16%)
Dec 10, 2025, 3:30 PM KST
OliX Pharmaceuticals Market Cap
OliX Pharmaceuticals has a market cap or net worth of 2.51 trillion as of December 10, 2025. Its market cap has increased by 589.64% in one year.
Market Cap
2.51T
Enterprise Value
2.41T
Revenue
10.18B
Ranking
n/a
PE Ratio
n/a
Stock Price
132,700.00
Market Cap Chart
Since July 18, 2018, OliX Pharmaceuticals's market cap has increased from 422.03B to 2.51T, an increase of 495.78%. That is a compound annual growth rate of 27.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 2.51T | 607.21% |
| Dec 30, 2024 | 355.53B | 52.22% |
| Dec 28, 2023 | 233.57B | -16.24% |
| Dec 29, 2022 | 278.86B | -50.37% |
| Dec 30, 2021 | 561.83B | -17.52% |
| Dec 30, 2020 | 681.17B | 146.02% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.41T |
| Celltrion | 40.94T |
| ALTEOGEN | 24.49T |
| SK Biopharmaceuticals | 10.44T |
| ABL Bio | 10.26T |
| Yuhan | 8.70T |
| LigaChem Biosciences | 6.67T |
| HLB Co., Ltd. | 6.53T |